Management Team.
The company’s stock symbol is HXBM.OB. For a complete listing of reports and filings please visit the Securities and Exchange Commission at…click to learn more
Management Team…click to learn more.
Board of Directors…click to learn more.
The Management and Board of Directors of Helix BioMedix Inc. are committed to operating the company in an efficient, compliant and ethical manner, thereby improving our ability for growth and creation of value for our stockholders…click to learn more.
Helix BioMedix, Inc. is pleased to offer the following online services…click to learn more.

Online Access to Annual Report and Proxy Statement
Electronic Proxy Voting
Beneficial Stockholders
Registered Stockolders

Management Team

Robin L. Carmichael, President and Chief Executive Officer
Robin L Carmichael was appointed our President and Chief Executive Officer in July 2017. Prior to this role, she served as president from February 2015 and had served as our chief operating officer since January 2011. She has served as a member of our board of directors since February 2013 and also serves on the board of Solomomo, a company focused on building high-tech products for the skincare, beauty and wellness markets since 2016. Ms. Carmichael joined Helix BioMedix in October 2007 as our vice president of marketing and business development. Prior to joining us, Ms. Carmichael served as chief operating officer of DERMAdoctor, Inc., a prestige cosmeceutical company. She was Vice President of Marketing with ProCyte Corporation from 1998 to 2005 and later of PhotoMedex, Inc. following its acquisition of ProCyte in 2005. During her tenure at ProCyte, she developed and launched seven major product lines, created several new brands, established the international distribution business and was actively involved with the various licensing partners. Ms. Carmichael has over 25 years of sales and marketing experience having held a number of regional and national sales positions in the life science and medical device companies, including Baxter Healthcare. She holds a Bachelor of Science in Nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management. She is a recognized speaker and author on numerous topics, including peptides, cosmetic surgery and skin care and is a member of Cosmetic Executive Women.
Ms. Carmichael has significant senior-level management experience in the biotechnology and consumer products industries and brings to our board valuable knowledge of the strategic, marketing and operational aspects of the biotechnology and consumer products industries. Her experience makes her a strong contributor to our board.
R.Stephen Beatty, Executive Chairman of the Board and Chief Investor Officer
R. Stephen Beatty was appointed Executive Chairman of the Board and Chief Investor Officer in July 2017. Prior to this role he served as our chief executive officer and a member of our board of directors since May 1999, and also served as our president during that time until he was appointed as chairman of the board in February 2015. Prior to joining us, Mr. Beatty established and operated Beatty Finance, Inc., a private financial services company. Mr. Beatty holds a B.S. in Mathematics from the University of South Alabama and an M.B.A. from the University of New Orleans.
Having served as our chief executive officer for over ten years, Mr. Beatty brings to the board of directors critical knowledge and understanding of the products offered by our company, proven management experience, and a thorough understanding of the biotechnology industry in which we operate. In addition, his years of experience owning and operating a financial services company give him valuable insight in the fields of finance and investment.
Dr. Lijuan Zhang, Senior Director of R&D Innovation
Dr Lijuan Zhang is an internationally recognized scientist and the Senior Director of R & D Innovation at Helix BioMedix, Inc. She is responsible for the development of new technologies for the aesthetic, dermatology and medical markets. Her leading-edge work has focused on the molecular modulation of the innate immune system to improve skin’s function, appearance, integrity and health. These efforts have resulted in the development of the Company’s patented Smartpeptides® technology, a new and effective way to improve skin health. Dr Zhang has authored over 38 peer reviewed papers and book chapters, presented at numerous international scientific conferences and is an inventor on over 42 patents and patent applications. Dr Zhang has a B.Sc. in microbiology from Northwestern University, China, a M.Sc. in molecular biology from the Chinese Academy of Science and Technology, Beijing and she received her doctorate from the University of Turku, Finland in 1996 followed by post-doctoral fellowships at the University of British Columbia, Canada. Dr Zhang has been a dedicated member of the Helix BioMedix team since 2001.